Simplex Trading’s Nuvation Bio NUVB Stock Holding History

Simplex Trading’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.1K	Sell	4,066 -30,272	-88%	-$148K	﹤0.01%	6979
2026 Q1	$147K	Buy	+34,338	New	+$191K	﹤0.01%	4652
2025 Q4	–	Sell	-115,559	Closed	-$716K	–	9600
2025 Q3	$427K	Buy	115,559 +77,905	+207%	+$212K	﹤0.01%	4026
2025 Q2	$73K	Buy	37,654 +26,707	+244%	+$55.6K	﹤0.01%	5539
2025 Q1	$19K	Sell	10,947 -41,790	-79%	-$95.1K	﹤0.01%	6618
2024 Q4	$140K	Buy	52,737 +5,040	+11%	+$13K	﹤0.01%	4865
2024 Q3	$109K	Buy	47,697 +40,641	+576%	+$124K	﹤0.01%	5135
2024 Q2	$20K	Buy	+7,056	New	+$21.5K	﹤0.01%	6897
2023 Q3	–	Sell	-18	Closed	-$30	–	9469
2023 Q2	$0	Buy	+18	New	+$31	﹤0.01%	9616
2022 Q3	–	Sell	-300	Closed	–	–	10585
2022 Q2	$0	Buy	+300	New	+$1.31K	﹤0.01%	10723
2021 Q4	–	Sell	-1,827	Closed	-$16.8K	–	11116
2021 Q3	$17K	Hold	1,827	–	–	﹤0.01%	8569
2021 Q2	$17K	Buy	+1,827	New	+$20.8K	﹤0.01%	8720

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Simplex Trading's NUVB Position: Q2 2026 in Review

Simplex Trading reduced its Nuvation Bio (NUVB) stake by 88% in Q2 2026, selling an estimated $148K and leaving 4,066 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6979.

Simplex Trading first reported a position in NUVB in Q2 2021 and has held it in 12 quarters since. The position peaked at $427K in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Simplex Trading held 4,066 shares of Nuvation Bio worth $23.1K as of Q2 2026.
Simplex Trading sold 30,272 Nuvation Bio shares in Q2 2026, an estimated $148K.
Nuvation Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6979 holding.
Simplex Trading first reported a position in Nuvation Bio in Q2 2021 and has held it in 12 quarters since.
Simplex Trading's Nuvation Bio position peaked at $427K in Q3 2025.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.